WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 5'9501 Infant (under 12 months) mortality rate: 232
GDP / capita (US$): 13'1071 Child (under 5 years) mortality rate: 272

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 10'529  10'404  10'277  10'148  10'017  8'663  7'245  5'826 
Births 215  217  218  219  219  217  217  200 
Surviving infants 210  211  212  213  213  208  205  184 
Pop. less than 5 years 1'059  1'061  1'063  1'065  1'068  1'027  998  883 
Pop. less than 15 years 3'149  3'142  3'134  3'127  3'123  3'027  2'791  2'480 
Female 15-49 years 2'741  2'715  2'688  2'659  2'627  2'244  1'792  1'366 

Number of reported case

(Click for retrospective incidence data for Dominican Republic (the))
Diphtheria 52  27  187 
Japanese encephalitis
Measles 253  3'477  9'760 
Mumps 498  2'760 
Pertussis 98  17  11  37  40  227  558 
Polio* 11  148 
Rubella 818 
Rubella (CRS)
Tetanus (neonatal) 12  14 
Tetanus (total)** 45  55  40  45  50  25  56  113 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Dominican Republic (the))
Vaccine year result method % card seen                                                
BCG 2012  92  DHS   70  99*  99  99*  99*  98  90  68  29 
DTP1 2012  90  DHS   70  99*  91  93  91  96 
DTP3 2012  77  DHS   70  91  83  85  84  88  78  69  36 
DTP4          78 
IPV1         
HepB_BD          82  78  74  82  80 
HepB3 2012  77  DHS   70  89  80  74  80  83  68 
Hib3 2012  77  DHS   70  87  75  70  71  81 
JapEnc         
MCV1          88  83  88  88  88  88  96  30 
MCV2         
PCV1          94  88  33 
PCV3          27 
Pol3 2012  66  DHS   70  90  82  85  84  85  67  90  46 
Rota1          96  81  59 
Rota_last          86  69  34 
Rubella1          87  83  88  88  87 
TT2plus 2012  78  DHS   70  86  87  90  63  13  25 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Dominican Republic (the))
BCG 99  99  99  99  98  90  70  29 
DTP1 91  91  92  91  96  91  87  61 
DTP3 91  83  85  84  88  78  69  36 
HepB3 89  80  74  80  83  68 
HepB_BD 67  63  59  67  65 
Hib3 87  75  70  71  81 
MCV1 88  83  88  87  85  85  70  30 
MCV2
PAB 90  90  90  90  87  48  60  23 
PCV3 27 
Pol3 90  82  85  84  85  71  90  46 
Rota_last 86  69 

Number of districts in the country 155  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
99 
   
/
|
|
\
Greater or equal to 90% 52
From 80 to 89% 14
From 50 to 79% 26
Less than 50% 7
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 2, 4, 6, 18 months; 5, 10 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult st contact; +1, +6 months; Yes
HepB_Pediatric birth; Yes
Influenza 6-24 months; >= 65 years; and risk groups and PW
MMR 12 months; Yes
MR >= 2 years; Yes
MenAC No special groups
OPV 2, 4, 6, 18 months; 4 years; Yes
Pneumo_conj 2, 4, 12 months; Yes
Pneumo_ps >= 2 years; No
Rabies Yes post exposure
Rotavirus 2, 4 months; Yes
Td 1st contact; + 1 month; +6 months; +1, +10, +20 year; Yes every 10 years
YF No travelers

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR No  No  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number       2010-2015  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number   68      75     

System performance

Total Nº districts in country number 155  155  155  155  155  155  155 
Nº districts with DTP3 coverage >=80% number 102  76  75  68  93  65  67 
% of districts with DTP3 coverage >=80% From 0 to 100% 66  49  48  44  60  42  43 
Nº districts with measles (MCV1) coverage >=95% number 53  28  46  47  38  42  42 
% of districts with MCV1 coverage >=95% From 0 to 100% 34  18  30  30  25  27  27 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  No  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  No  No    Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 94  99  99  45  100  90  90 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No    No     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.